Implementation Guide CH VACD
3.0.0 - STU3
Implementation Guide CH VACD
3.0.0 - STU3
This page is part of the CH VACD (R4) (v3.0.0: STU 3) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
| Active as of 2022-12-21 |
{
"resourceType" : "CodeSystem",
"id" : "ch-vacd-complication-risks-cs",
"meta" : {
"source" : "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-complication-risks-vs"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system <code>http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-complication-risks-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">113001<a name=\"ch-vacd-complication-risks-cs-113001\"> </a></td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td></tr><tr><td style=\"white-space:nowrap\">114036<a name=\"ch-vacd-complication-risks-cs-114036\"> </a></td><td>ANDERE_LEBERERKRANKUNG</td></tr><tr><td style=\"white-space:nowrap\">114006<a name=\"ch-vacd-complication-risks-cs-114006\"> </a></td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td></tr><tr><td style=\"white-space:nowrap\">114033<a name=\"ch-vacd-complication-risks-cs-114033\"> </a></td><td>ANDERE_NIERENERKRANKUNG</td></tr><tr><td style=\"white-space:nowrap\">114034<a name=\"ch-vacd-complication-risks-cs-114034\"> </a></td><td>ANDERER_KREBS</td></tr><tr><td style=\"white-space:nowrap\">114025<a name=\"ch-vacd-complication-risks-cs-114025\"> </a></td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td></tr><tr><td style=\"white-space:nowrap\">114021<a name=\"ch-vacd-complication-risks-cs-114021\"> </a></td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td></tr><tr><td style=\"white-space:nowrap\">114005<a name=\"ch-vacd-complication-risks-cs-114005\"> </a></td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td></tr><tr><td style=\"white-space:nowrap\">114003<a name=\"ch-vacd-complication-risks-cs-114003\"> </a></td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td></tr><tr><td style=\"white-space:nowrap\">114007<a name=\"ch-vacd-complication-risks-cs-114007\"> </a></td><td>CHRONISCHE_LEBERERKRANKUNG</td></tr><tr><td style=\"white-space:nowrap\">113002<a name=\"ch-vacd-complication-risks-cs-113002\"> </a></td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td></tr><tr><td style=\"white-space:nowrap\">114015<a name=\"ch-vacd-complication-risks-cs-114015\"> </a></td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td></tr><tr><td style=\"white-space:nowrap\">114019<a name=\"ch-vacd-complication-risks-cs-114019\"> </a></td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td></tr><tr><td style=\"white-space:nowrap\">114020<a name=\"ch-vacd-complication-risks-cs-114020\"> </a></td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td></tr><tr><td style=\"white-space:nowrap\">113004<a name=\"ch-vacd-complication-risks-cs-113004\"> </a></td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td></tr><tr><td style=\"white-space:nowrap\">114037<a name=\"ch-vacd-complication-risks-cs-114037\"> </a></td><td>HAEMODIALYSEPATIENT</td></tr><tr><td style=\"white-space:nowrap\">114038<a name=\"ch-vacd-complication-risks-cs-114038\"> </a></td><td>HAEMOPHILIE_PATIENT</td></tr><tr><td style=\"white-space:nowrap\">114001<a name=\"ch-vacd-complication-risks-cs-114001\"> </a></td><td>HERZINSUFFIZIENZ</td></tr><tr><td style=\"white-space:nowrap\">113007<a name=\"ch-vacd-complication-risks-cs-113007\"> </a></td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td></tr><tr><td style=\"white-space:nowrap\">113008<a name=\"ch-vacd-complication-risks-cs-113008\"> </a></td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td></tr><tr><td style=\"white-space:nowrap\">113009<a name=\"ch-vacd-complication-risks-cs-113009\"> </a></td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td></tr><tr><td style=\"white-space:nowrap\">114018<a name=\"ch-vacd-complication-risks-cs-114018\"> </a></td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td></tr><tr><td style=\"white-space:nowrap\">114002<a name=\"ch-vacd-complication-risks-cs-114002\"> </a></td><td>KARDIOPATHIE</td></tr><tr><td style=\"white-space:nowrap\">114008<a name=\"ch-vacd-complication-risks-cs-114008\"> </a></td><td>LEBERZIRRHOSE</td></tr><tr><td style=\"white-space:nowrap\">113012<a name=\"ch-vacd-complication-risks-cs-113012\"> </a></td><td>LYMPHOM_LEUKAEMIE_MYELOM</td></tr><tr><td style=\"white-space:nowrap\">118001<a name=\"ch-vacd-complication-risks-cs-118001\"> </a></td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td></tr><tr><td style=\"white-space:nowrap\">113014<a name=\"ch-vacd-complication-risks-cs-113014\"> </a></td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td></tr><tr><td style=\"white-space:nowrap\">114026<a name=\"ch-vacd-complication-risks-cs-114026\"> </a></td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td></tr><tr><td style=\"white-space:nowrap\">114022<a name=\"ch-vacd-complication-risks-cs-114022\"> </a></td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td></tr><tr><td style=\"white-space:nowrap\">114016<a name=\"ch-vacd-complication-risks-cs-114016\"> </a></td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td></tr><tr><td style=\"white-space:nowrap\">113018<a name=\"ch-vacd-complication-risks-cs-113018\"> </a></td><td>NEPHROTISCHES_SYNDROM</td></tr><tr><td style=\"white-space:nowrap\">114012<a name=\"ch-vacd-complication-risks-cs-114012\"> </a></td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td></tr><tr><td style=\"white-space:nowrap\">113023<a name=\"ch-vacd-complication-risks-cs-113023\"> </a></td><td>NIERENINSUFFIZIENZ</td></tr><tr><td style=\"white-space:nowrap\">114035<a name=\"ch-vacd-complication-risks-cs-114035\"> </a></td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td></tr><tr><td style=\"white-space:nowrap\">113035<a name=\"ch-vacd-complication-risks-cs-113035\"> </a></td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td></tr><tr><td style=\"white-space:nowrap\">114032<a name=\"ch-vacd-complication-risks-cs-114032\"> </a></td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td></tr><tr><td style=\"white-space:nowrap\">114028<a name=\"ch-vacd-complication-risks-cs-114028\"> </a></td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td></tr><tr><td style=\"white-space:nowrap\">113021<a name=\"ch-vacd-complication-risks-cs-113021\"> </a></td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td></tr><tr><td style=\"white-space:nowrap\">114004<a name=\"ch-vacd-complication-risks-cs-114004\"> </a></td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td></tr><tr><td style=\"white-space:nowrap\">114014<a name=\"ch-vacd-complication-risks-cs-114014\"> </a></td><td>SICHELZELLANAEMIE</td></tr><tr><td style=\"white-space:nowrap\">113036<a name=\"ch-vacd-complication-risks-cs-113036\"> </a></td><td>ZOELIAKIE</td></tr></table><p><b>Additional Language Displays</b></p><table class=\"codes\"><tr><td><b>Code</b></td><td><b>Deutsch (Schweiz) (German (Switzerland), de)</b></td><td><b>English (United States) (English (United States), en)</b></td><td><b>French (Switzerland) (fr)</b></td><td><b>Italian (Switzerland) (it)</b></td><td><b>rm</b></td></tr><tr><td>113001</td><td>Anatomische oder funktionelle Asplenie</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td>Asplénie anatomique ou fonctionnelle</td><td>Asplenia anatomica o funzionale</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td></tr><tr><td>114036</td><td>andere Lebererkrankung</td><td>ANDERE_LEBERERKRANKUNG</td><td>autre maladie hépatique</td><td>altra malattia epatica</td><td>ANDERE_LEBERERKRANKUNG</td></tr><tr><td>114006</td><td>Andere Lungenerkrankungen (z.B. Mukoviszidose, Asthma bronchiale, etc.)</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td>Autres maladies pulmonaires (ex : mucoviscidose, asthme traité par aérosols, etc)</td><td>Altre malattie polmonari (p.es. mucoviscidosi, asmatrattata con aerosol, ecc.)</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td></tr><tr><td>114033</td><td>Andere Nierenerkrankung</td><td>ANDERE_NIERENERKRANKUNG</td><td>autre maladie des reins</td><td>altra malattia renale</td><td>ANDERE_NIERENERKRANKUNG</td></tr><tr><td>114034</td><td>Anderer Krebs</td><td>ANDERER_KREBS</td><td>autre cancer</td><td>altro cancro</td><td>ANDERER_KREBS</td></tr><tr><td>114025</td><td>Angeborene Immundefizienz, variables Immundefektsyndrom, defizitäre Antwort auf Polysaccharide</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td>Immunodéficience congénitale, immunodéficience commune variable, déficit réponse aux polysaccharidiques</td><td>Immunodeficienza congenita, immunodeficienza comune variabile, deficit di risposta ai polisaccaridi</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td></tr><tr><td>114021</td><td>Autoimmunkrankheit, welche eine Immunsuppression erfordert</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td>Maladie auto-immune exigeant vraisemblablement une immunosuppression</td><td>Malattia autoimmune che richiede probabilmente una immunosoppressione</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td></tr><tr><td>114005</td><td>Bronchiektasen durch Antikörpermangel</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td>Bronchiectasies sur carence en anticorps</td><td>Bronchiettasie su carenza in anticorpi</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td></tr><tr><td>114003</td><td>Chronisch obstruktive Pneumopathie</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td>Pneumopathie chronique obstructive</td><td>Pneumopatia cronica ostruttiva</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td></tr><tr><td>114007</td><td>Chronische Lebererkrankung</td><td>CHRONISCHE_LEBERERKRANKUNG</td><td>Maladie hépatique chronique</td><td>Malattia epatica cronica</td><td>CHRONISCHE_LEBERERKRANKUNG</td></tr><tr><td>113002</td><td>Cochleaimplantat, in situ oder geplant</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td>Implant cochléaire, in situ ou planifié</td><td>Impianto cocleare, in situ o pianificato</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td></tr><tr><td>114015</td><td>Diabetes mit Auswirkung auf die Funktion von Herz, Lungen oder Nieren</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td>Diabète avec répercussion sur la fonction cardiaque, pulmonaire ou rénale</td><td>Diabete con ripercussioni sulla funzione cardiopolmonare o renale</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td></tr><tr><td>114019</td><td>Empfänger einer Solidorgantransplantation</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td>Receveurs d'une transplantation d'organe solide</td><td>Riceventi di un trapianto d'organo solido</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td></tr><tr><td>114020</td><td>Empfänger einer Stammzelltransplantation</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td>Receveurs de cellules souches hématopoïétiques</td><td>Riceventi di cellule staminali ematopoietiche</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td></tr><tr><td>113004</td><td>Geburt vor der 33. Schwangerschaftswoche oder Geburtsgewicht < 1500g</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td>Naissance avant la 33e semaine de grossesse ou poids de naissance <1500g</td><td>Nascita prima della 33a settimana di gravidanza o peso alla nascita <1500g</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td></tr><tr><td>114037</td><td>Hämodialysepatient</td><td>HAEMODIALYSEPATIENT</td><td>Personnes dialysées</td><td>Persone in dialisi</td><td>HAEMODIALYSEPATIENT</td></tr><tr><td>114038</td><td>Hämophilie Patient</td><td>HAEMOPHILIE_PATIENT</td><td>Personnes hémophiles</td><td>Persone affette da emofilia</td><td>HAEMOPHILIE_PATIENT</td></tr><tr><td>114001</td><td>Herzinsuffizienz</td><td>HERZINSUFFIZIENZ</td><td>Insuffisance cardiaque</td><td>Insufficienza cardiaca</td><td>HERZINSUFFIZIENZ</td></tr><tr><td>113007</td><td>Herzkrankheiten (chronische, kongenitale Missbildungen)</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td>Cardiopathies chroniques, malformations congénitales</td><td>Cardiopatie croniche, malformazioni congenite</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td></tr><tr><td>113008</td><td>HIV Infektion mit CD4-Zellen >= 15 % (Erwachsene: >= 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td>Infection à VIH avec CD4 >= 15% (Adultes : >= 200 / µl)</td><td>Infezione HIV con CD4 >= 15% (Adulti : >= 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td></tr><tr><td>113009</td><td>HIV Infektion mit CD4-Zellen < 15 % (Erwachsene: < 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td>Infection à VIH avec CD4 < 15% (Adultes : < 200 / µl)</td><td>Infezione HIV con CD4 < 15% (Adulti : < 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td></tr><tr><td>114018</td><td>Kandidaten für eine Solidorgantransplantation</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td>Candidats à une transplantation d'organe solide</td><td>Candidati a un trapianto d'organo solido</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td></tr><tr><td>114002</td><td>Kardiopathie, angeborene Fehlbildung</td><td>KARDIOPATHIE</td><td>Cardiopathie, malformation congénitale</td><td>Cardiopatia, malformazione congenita</td><td>KARDIOPATHIE</td></tr><tr><td>114008</td><td>Leberzirrhose</td><td>LEBERZIRRHOSE</td><td>Cirrhose hépatique</td><td>Cirrosi epatica</td><td>LEBERZIRRHOSE</td></tr><tr><td>113012</td><td>Lymphom, Leukämie, Myelom</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td>Lymphome, leucémie, myélome</td><td>Linfoma, leucemia, mieloma</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td></tr><tr><td>118001</td><td>Lymphom, Leukämie, Myelom während klinischer Remission</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td>Lymphome, leucémie, myélome durant une rémission clinique</td><td>Linfoma, leucemia, mieloma durante una remissione clinica</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td></tr><tr><td>113014</td><td>Mangel an Mannose-bindendem Lektin</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td>Déficit en lectine liant le mannose</td><td>Deficit di lectina legante il mannosio</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td></tr><tr><td>114026</td><td>Mangel im klassischen oder alternativen Weg der Komplementaktivierung</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td>Déficit en facteurs de la voie alterne ou terminale du complément</td><td>Deficit in fattori della via alterna o terminale del complemento</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td></tr><tr><td>114022</td><td>Medikamentöse Immunosuppression (inkl. systemische Langzeitkortikoidtherapie und Radiotherapie)</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td>Immunosuppression médicamenteuse (y c. corticothérapie de longue durée par voie générale et radiothérapie)</td><td>Immunosoppressione medicamentosa (compresa una corticoterapia di lunga durata per via generale e una radioterapia)</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td></tr><tr><td>114016</td><td>Morbide Adipositas (BMI >= 40)</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td>Obésité morbide (IMC >= 40)</td><td>Obesità patologica (IMC >= 40)</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td></tr><tr><td>113018</td><td>Nephrotisches Syndrom</td><td>NEPHROTISCHES_SYNDROM</td><td>Syndrome néphrotique</td><td>Sindrome nefrosica</td><td>NEPHROTISCHES_SYNDROM</td></tr><tr><td>114012</td><td>Neuromuskuläre Krankheit (Falls Auswirkungen auf Herz-, Lungen- oder Nierenfunktion)</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td>Maladie neuromusculaire (Si répercussion sur la fonction cardiaque, pulmonaire ou rénale)</td><td>Malattia neuromuscolare (Se ripercussione sulla funzione cardiaca, polmonare o renale)</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td></tr><tr><td>113023</td><td>Niereninsuffizienz</td><td>NIERENINSUFFIZIENZ</td><td>Insuffisance rénale</td><td>Insufficienza renale</td><td>NIERENINSUFFIZIENZ</td></tr><tr><td>114035</td><td>Protein-S oder Protein-C Defizit</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td>déficit en protéine S et protéine C</td><td>deficit di proteina S e proteina C</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td></tr><tr><td>113035</td><td>Rheumatismus oder Autoimmunkrankheit, welche eine Immunsuppression bedingt</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td>Maladie rhumatismale ou auto-immune allant nécessiter une immunosuppression</td><td>Malattia reumatica o autoimmune che presto richiederà l'immunosoppressione</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td></tr><tr><td>114032</td><td>Schädelbasisfraktur /-Missbildung, zerebrospinale Liquorfistel</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td>Fracture ou malformation de la base du crâne, fistule de liquide céphalo-rachidien</td><td>Frattura o malformazione della base del cranio, fistola di liquido cerebrospinale</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td></tr><tr><td>114028</td><td>Schwangerschaft und post-partum Periode</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td>Grossesse et post-partum</td><td>Gravidanza e post-parto</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td></tr><tr><td>113021</td><td>Schwere Neurodermitis beim Kind</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td>Eczema sévère chez l’enfant</td><td>Eczema severo nel bambino</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td></tr><tr><td>114004</td><td>Schweres Asthma: bei verlängerter oder häufiger Behandlung mit oralen Steroiden</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td>Asthme sévère : si traitement prolongé ou fréquent par des corticoïdes oraux</td><td>Asma severa : se trattamento prolungato o frequente con corticoidi orali</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td></tr><tr><td>114014</td><td>Sichelzellanämie</td><td>SICHELZELLANAEMIE</td><td>Anémie falciforme</td><td>Anemia falciforme</td><td>SICHELZELLANAEMIE</td></tr><tr><td>113036</td><td>Zöliakie</td><td>ZOELIAKIE</td><td>Coeliaquie</td><td>Celiachia</td><td>ZOELIAKIE</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
"valuePeriod" : {
"start" : "2021-01-24T00:00:00+01:00"
}
}
],
"url" : "http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-complication-risks-cs",
"identifier" : [
{
"use" : "official",
"system" : "http://art-decor.org/ns/oids/vs",
"value" : "urn:oid:2.16.756.5.30.1.127.3.3.1"
}
],
"version" : "3.0.0",
"name" : "SwissComplicationRisksCodesystem",
"title" : "Swiss Complication Risks Codesystem",
"status" : "active",
"experimental" : false,
"date" : "2022-12-21T13:48:44+01:00",
"publisher" : "HL7 Switzerland",
"contact" : [
{
"name" : "HL7 Switzerland",
"telecom" : [
{
"system" : "url",
"value" : "https://www.hl7.ch/"
}
]
}
],
"description" : "Complication/medical risks available in Switzerland.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "CHE"
}
]
}
],
"copyright" : "CC-BY-SA-4.0",
"caseSensitive" : true,
"content" : "complete",
"count" : 41,
"concept" : [
{
"code" : "113001",
"display" : "ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE",
"designation" : [
{
"language" : "de-CH",
"value" : "Anatomische oder funktionelle Asplenie"
},
{
"language" : "fr-CH",
"value" : "Asplénie anatomique ou fonctionnelle"
},
{
"language" : "it-CH",
"value" : "Asplenia anatomica o funzionale"
},
{
"language" : "rm-CH",
"value" : "ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE"
},
{
"language" : "en-US",
"value" : "ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE"
}
]
},
{
"code" : "114036",
"display" : "ANDERE_LEBERERKRANKUNG",
"designation" : [
{
"language" : "de-CH",
"value" : "andere Lebererkrankung"
},
{
"language" : "fr-CH",
"value" : "autre maladie hépatique"
},
{
"language" : "it-CH",
"value" : "altra malattia epatica"
},
{
"language" : "rm-CH",
"value" : "ANDERE_LEBERERKRANKUNG"
},
{
"language" : "en-US",
"value" : "ANDERE_LEBERERKRANKUNG"
}
]
},
{
"code" : "114006",
"display" : "ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC",
"designation" : [
{
"language" : "de-CH",
"value" : "Andere Lungenerkrankungen (z.B. Mukoviszidose, Asthma bronchiale, etc.)"
},
{
"language" : "fr-CH",
"value" : "Autres maladies pulmonaires (ex : mucoviscidose, asthme traité par aérosols, etc)"
},
{
"language" : "it-CH",
"value" : "Altre malattie polmonari (p.es. mucoviscidosi, asmatrattata con aerosol, ecc.)"
},
{
"language" : "rm-CH",
"value" : "ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC"
},
{
"language" : "en-US",
"value" : "ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC"
}
]
},
{
"code" : "114033",
"display" : "ANDERE_NIERENERKRANKUNG",
"designation" : [
{
"language" : "de-CH",
"value" : "Andere Nierenerkrankung"
},
{
"language" : "fr-CH",
"value" : "autre maladie des reins"
},
{
"language" : "it-CH",
"value" : "altra malattia renale"
},
{
"language" : "rm-CH",
"value" : "ANDERE_NIERENERKRANKUNG"
},
{
"language" : "en-US",
"value" : "ANDERE_NIERENERKRANKUNG"
}
]
},
{
"code" : "114034",
"display" : "ANDERER_KREBS",
"designation" : [
{
"language" : "de-CH",
"value" : "Anderer Krebs"
},
{
"language" : "fr-CH",
"value" : "autre cancer"
},
{
"language" : "it-CH",
"value" : "altro cancro"
},
{
"language" : "rm-CH",
"value" : "ANDERER_KREBS"
},
{
"language" : "en-US",
"value" : "ANDERER_KREBS"
}
]
},
{
"code" : "114025",
"display" : "ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE",
"designation" : [
{
"language" : "de-CH",
"value" : "Angeborene Immundefizienz, variables Immundefektsyndrom, defizitäre Antwort auf Polysaccharide"
},
{
"language" : "fr-CH",
"value" : "Immunodéficience congénitale, immunodéficience commune variable, déficit réponse aux polysaccharidiques"
},
{
"language" : "it-CH",
"value" : "Immunodeficienza congenita, immunodeficienza comune variabile, deficit di risposta ai polisaccaridi"
},
{
"language" : "rm-CH",
"value" : "ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE"
},
{
"language" : "en-US",
"value" : "ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE"
}
]
},
{
"code" : "114021",
"display" : "AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT",
"designation" : [
{
"language" : "de-CH",
"value" : "Autoimmunkrankheit, welche eine Immunsuppression erfordert"
},
{
"language" : "fr-CH",
"value" : "Maladie auto-immune exigeant vraisemblablement une immunosuppression"
},
{
"language" : "it-CH",
"value" : "Malattia autoimmune che richiede probabilmente una immunosoppressione"
},
{
"language" : "rm-CH",
"value" : "AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT"
},
{
"language" : "en-US",
"value" : "AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT"
}
]
},
{
"code" : "114005",
"display" : "BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL",
"designation" : [
{
"language" : "de-CH",
"value" : "Bronchiektasen durch Antikörpermangel"
},
{
"language" : "fr-CH",
"value" : "Bronchiectasies sur carence en anticorps"
},
{
"language" : "it-CH",
"value" : "Bronchiettasie su carenza in anticorpi"
},
{
"language" : "rm-CH",
"value" : "BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL"
},
{
"language" : "en-US",
"value" : "BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL"
}
]
},
{
"code" : "114003",
"display" : "CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE",
"designation" : [
{
"language" : "de-CH",
"value" : "Chronisch obstruktive Pneumopathie"
},
{
"language" : "fr-CH",
"value" : "Pneumopathie chronique obstructive"
},
{
"language" : "it-CH",
"value" : "Pneumopatia cronica ostruttiva"
},
{
"language" : "rm-CH",
"value" : "CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE"
},
{
"language" : "en-US",
"value" : "CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE"
}
]
},
{
"code" : "114007",
"display" : "CHRONISCHE_LEBERERKRANKUNG",
"designation" : [
{
"language" : "de-CH",
"value" : "Chronische Lebererkrankung"
},
{
"language" : "fr-CH",
"value" : "Maladie hépatique chronique"
},
{
"language" : "it-CH",
"value" : "Malattia epatica cronica"
},
{
"language" : "rm-CH",
"value" : "CHRONISCHE_LEBERERKRANKUNG"
},
{
"language" : "en-US",
"value" : "CHRONISCHE_LEBERERKRANKUNG"
}
]
},
{
"code" : "113002",
"display" : "COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT",
"designation" : [
{
"language" : "de-CH",
"value" : "Cochleaimplantat, in situ oder geplant"
},
{
"language" : "fr-CH",
"value" : "Implant cochléaire, in situ ou planifié"
},
{
"language" : "it-CH",
"value" : "Impianto cocleare, in situ o pianificato"
},
{
"language" : "rm-CH",
"value" : "COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT"
},
{
"language" : "en-US",
"value" : "COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT"
}
]
},
{
"code" : "114015",
"display" : "DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN",
"designation" : [
{
"language" : "de-CH",
"value" : "Diabetes mit Auswirkung auf die Funktion von Herz, Lungen oder Nieren"
},
{
"language" : "fr-CH",
"value" : "Diabète avec répercussion sur la fonction cardiaque, pulmonaire ou rénale"
},
{
"language" : "it-CH",
"value" : "Diabete con ripercussioni sulla funzione cardiopolmonare o renale"
},
{
"language" : "rm-CH",
"value" : "DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN"
},
{
"language" : "en-US",
"value" : "DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN"
}
]
},
{
"code" : "114019",
"display" : "EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION",
"designation" : [
{
"language" : "de-CH",
"value" : "Empfänger einer Solidorgantransplantation"
},
{
"language" : "fr-CH",
"value" : "Receveurs d'une transplantation d'organe solide"
},
{
"language" : "it-CH",
"value" : "Riceventi di un trapianto d'organo solido"
},
{
"language" : "rm-CH",
"value" : "EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION"
},
{
"language" : "en-US",
"value" : "EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION"
}
]
},
{
"code" : "114020",
"display" : "EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION",
"designation" : [
{
"language" : "de-CH",
"value" : "Empfänger einer Stammzelltransplantation"
},
{
"language" : "fr-CH",
"value" : "Receveurs de cellules souches hématopoïétiques"
},
{
"language" : "it-CH",
"value" : "Riceventi di cellule staminali ematopoietiche"
},
{
"language" : "rm-CH",
"value" : "EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION"
},
{
"language" : "en-US",
"value" : "EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION"
}
]
},
{
"code" : "113004",
"display" : "GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G",
"designation" : [
{
"language" : "de-CH",
"value" : "Geburt vor der 33. Schwangerschaftswoche oder Geburtsgewicht < 1500g"
},
{
"language" : "fr-CH",
"value" : "Naissance avant la 33e semaine de grossesse ou poids de naissance <1500g"
},
{
"language" : "it-CH",
"value" : "Nascita prima della 33a settimana di gravidanza o peso alla nascita <1500g"
},
{
"language" : "rm-CH",
"value" : "GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G"
},
{
"language" : "en-US",
"value" : "GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G"
}
]
},
{
"code" : "114037",
"display" : "HAEMODIALYSEPATIENT",
"designation" : [
{
"language" : "de-CH",
"value" : "Hämodialysepatient"
},
{
"language" : "fr-CH",
"value" : "Personnes dialysées"
},
{
"language" : "it-CH",
"value" : "Persone in dialisi"
},
{
"language" : "rm-CH",
"value" : "HAEMODIALYSEPATIENT"
},
{
"language" : "en-US",
"value" : "HAEMODIALYSEPATIENT"
}
]
},
{
"code" : "114038",
"display" : "HAEMOPHILIE_PATIENT",
"designation" : [
{
"language" : "de-CH",
"value" : "Hämophilie Patient"
},
{
"language" : "fr-CH",
"value" : "Personnes hémophiles"
},
{
"language" : "it-CH",
"value" : "Persone affette da emofilia"
},
{
"language" : "rm-CH",
"value" : "HAEMOPHILIE_PATIENT"
},
{
"language" : "en-US",
"value" : "HAEMOPHILIE_PATIENT"
}
]
},
{
"code" : "114001",
"display" : "HERZINSUFFIZIENZ",
"designation" : [
{
"language" : "de-CH",
"value" : "Herzinsuffizienz"
},
{
"language" : "fr-CH",
"value" : "Insuffisance cardiaque"
},
{
"language" : "it-CH",
"value" : "Insufficienza cardiaca"
},
{
"language" : "rm-CH",
"value" : "HERZINSUFFIZIENZ"
},
{
"language" : "en-US",
"value" : "HERZINSUFFIZIENZ"
}
]
},
{
"code" : "113007",
"display" : "HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN",
"designation" : [
{
"language" : "de-CH",
"value" : "Herzkrankheiten (chronische, kongenitale Missbildungen)"
},
{
"language" : "fr-CH",
"value" : "Cardiopathies chroniques, malformations congénitales"
},
{
"language" : "it-CH",
"value" : "Cardiopatie croniche, malformazioni congenite"
},
{
"language" : "rm-CH",
"value" : "HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN"
},
{
"language" : "en-US",
"value" : "HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN"
}
]
},
{
"code" : "113008",
"display" : "HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL",
"designation" : [
{
"language" : "de-CH",
"value" : "HIV Infektion mit CD4-Zellen >= 15 % (Erwachsene: >= 200 / µl)"
},
{
"language" : "fr-CH",
"value" : "Infection à VIH avec CD4 >= 15% (Adultes : >= 200 / µl)"
},
{
"language" : "it-CH",
"value" : "Infezione HIV con CD4 >= 15% (Adulti : >= 200 / µl)"
},
{
"language" : "rm-CH",
"value" : "HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL"
},
{
"language" : "en-US",
"value" : "HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL"
}
]
},
{
"code" : "113009",
"display" : "HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL",
"designation" : [
{
"language" : "de-CH",
"value" : "HIV Infektion mit CD4-Zellen < 15 % (Erwachsene: < 200 / µl)"
},
{
"language" : "fr-CH",
"value" : "Infection à VIH avec CD4 < 15% (Adultes : < 200 / µl)"
},
{
"language" : "it-CH",
"value" : "Infezione HIV con CD4 < 15% (Adulti : < 200 / µl)"
},
{
"language" : "rm-CH",
"value" : "HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL"
},
{
"language" : "en-US",
"value" : "HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL"
}
]
},
{
"code" : "114018",
"display" : "KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION",
"designation" : [
{
"language" : "de-CH",
"value" : "Kandidaten für eine Solidorgantransplantation"
},
{
"language" : "fr-CH",
"value" : "Candidats à une transplantation d'organe solide"
},
{
"language" : "it-CH",
"value" : "Candidati a un trapianto d'organo solido"
},
{
"language" : "rm-CH",
"value" : "KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION"
},
{
"language" : "en-US",
"value" : "KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION"
}
]
},
{
"code" : "114002",
"display" : "KARDIOPATHIE",
"designation" : [
{
"language" : "de-CH",
"value" : "Kardiopathie, angeborene Fehlbildung"
},
{
"language" : "fr-CH",
"value" : "Cardiopathie, malformation congénitale"
},
{
"language" : "it-CH",
"value" : "Cardiopatia, malformazione congenita"
},
{
"language" : "rm-CH",
"value" : "KARDIOPATHIE"
},
{
"language" : "en-US",
"value" : "KARDIOPATHIE"
}
]
},
{
"code" : "114008",
"display" : "LEBERZIRRHOSE",
"designation" : [
{
"language" : "de-CH",
"value" : "Leberzirrhose"
},
{
"language" : "fr-CH",
"value" : "Cirrhose hépatique"
},
{
"language" : "it-CH",
"value" : "Cirrosi epatica"
},
{
"language" : "rm-CH",
"value" : "LEBERZIRRHOSE"
},
{
"language" : "en-US",
"value" : "LEBERZIRRHOSE"
}
]
},
{
"code" : "113012",
"display" : "LYMPHOM_LEUKAEMIE_MYELOM",
"designation" : [
{
"language" : "de-CH",
"value" : "Lymphom, Leukämie, Myelom"
},
{
"language" : "fr-CH",
"value" : "Lymphome, leucémie, myélome"
},
{
"language" : "it-CH",
"value" : "Linfoma, leucemia, mieloma"
},
{
"language" : "rm-CH",
"value" : "LYMPHOM_LEUKAEMIE_MYELOM"
},
{
"language" : "en-US",
"value" : "LYMPHOM_LEUKAEMIE_MYELOM"
}
]
},
{
"code" : "118001",
"display" : "LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION",
"designation" : [
{
"language" : "de-CH",
"value" : "Lymphom, Leukämie, Myelom während klinischer Remission"
},
{
"language" : "fr-CH",
"value" : "Lymphome, leucémie, myélome durant une rémission clinique"
},
{
"language" : "it-CH",
"value" : "Linfoma, leucemia, mieloma durante una remissione clinica"
},
{
"language" : "rm-CH",
"value" : "LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION"
},
{
"language" : "en-US",
"value" : "LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION"
}
]
},
{
"code" : "113014",
"display" : "MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN",
"designation" : [
{
"language" : "de-CH",
"value" : "Mangel an Mannose-bindendem Lektin"
},
{
"language" : "fr-CH",
"value" : "Déficit en lectine liant le mannose"
},
{
"language" : "it-CH",
"value" : "Deficit di lectina legante il mannosio"
},
{
"language" : "rm-CH",
"value" : "MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN"
},
{
"language" : "en-US",
"value" : "MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN"
}
]
},
{
"code" : "114026",
"display" : "MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG",
"designation" : [
{
"language" : "de-CH",
"value" : "Mangel im klassischen oder alternativen Weg der Komplementaktivierung"
},
{
"language" : "fr-CH",
"value" : "Déficit en facteurs de la voie alterne ou terminale du complément"
},
{
"language" : "it-CH",
"value" : "Deficit in fattori della via alterna o terminale del complemento"
},
{
"language" : "rm-CH",
"value" : "MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG"
},
{
"language" : "en-US",
"value" : "MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG"
}
]
},
{
"code" : "114022",
"display" : "MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE",
"designation" : [
{
"language" : "de-CH",
"value" : "Medikamentöse Immunosuppression (inkl. systemische Langzeitkortikoidtherapie und Radiotherapie)"
},
{
"language" : "fr-CH",
"value" : "Immunosuppression médicamenteuse (y c. corticothérapie de longue durée par voie générale et radiothérapie)"
},
{
"language" : "it-CH",
"value" : "Immunosoppressione medicamentosa (compresa una corticoterapia di lunga durata per via generale e una radioterapia)"
},
{
"language" : "rm-CH",
"value" : "MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE"
},
{
"language" : "en-US",
"value" : "MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE"
}
]
},
{
"code" : "114016",
"display" : "MORBIDE_ADIPOSITAS_BMI_GROESSER_40",
"designation" : [
{
"language" : "de-CH",
"value" : "Morbide Adipositas (BMI >= 40)"
},
{
"language" : "fr-CH",
"value" : "Obésité morbide (IMC >= 40)"
},
{
"language" : "it-CH",
"value" : "Obesità patologica (IMC >= 40)"
},
{
"language" : "rm-CH",
"value" : "MORBIDE_ADIPOSITAS_BMI_GROESSER_40"
},
{
"language" : "en-US",
"value" : "MORBIDE_ADIPOSITAS_BMI_GROESSER_40"
}
]
},
{
"code" : "113018",
"display" : "NEPHROTISCHES_SYNDROM",
"designation" : [
{
"language" : "de-CH",
"value" : "Nephrotisches Syndrom"
},
{
"language" : "fr-CH",
"value" : "Syndrome néphrotique"
},
{
"language" : "it-CH",
"value" : "Sindrome nefrosica"
},
{
"language" : "rm-CH",
"value" : "NEPHROTISCHES_SYNDROM"
},
{
"language" : "en-US",
"value" : "NEPHROTISCHES_SYNDROM"
}
]
},
{
"code" : "114012",
"display" : "NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION",
"designation" : [
{
"language" : "de-CH",
"value" : "Neuromuskuläre Krankheit (Falls Auswirkungen auf Herz-, Lungen- oder Nierenfunktion)"
},
{
"language" : "fr-CH",
"value" : "Maladie neuromusculaire (Si répercussion sur la fonction cardiaque, pulmonaire ou rénale)"
},
{
"language" : "it-CH",
"value" : "Malattia neuromuscolare (Se ripercussione sulla funzione cardiaca, polmonare o renale)"
},
{
"language" : "rm-CH",
"value" : "NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION"
},
{
"language" : "en-US",
"value" : "NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION"
}
]
},
{
"code" : "113023",
"display" : "NIERENINSUFFIZIENZ",
"designation" : [
{
"language" : "de-CH",
"value" : "Niereninsuffizienz"
},
{
"language" : "fr-CH",
"value" : "Insuffisance rénale"
},
{
"language" : "it-CH",
"value" : "Insufficienza renale"
},
{
"language" : "rm-CH",
"value" : "NIERENINSUFFIZIENZ"
},
{
"language" : "en-US",
"value" : "NIERENINSUFFIZIENZ"
}
]
},
{
"code" : "114035",
"display" : "PROTEIN_S_ODER_PROTEIN_C_DEFIZIT",
"designation" : [
{
"language" : "de-CH",
"value" : "Protein-S oder Protein-C Defizit"
},
{
"language" : "fr-CH",
"value" : "déficit en protéine S et protéine C"
},
{
"language" : "it-CH",
"value" : "deficit di proteina S e proteina C"
},
{
"language" : "rm-CH",
"value" : "PROTEIN_S_ODER_PROTEIN_C_DEFIZIT"
},
{
"language" : "en-US",
"value" : "PROTEIN_S_ODER_PROTEIN_C_DEFIZIT"
}
]
},
{
"code" : "113035",
"display" : "RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT",
"designation" : [
{
"language" : "de-CH",
"value" : "Rheumatismus oder Autoimmunkrankheit, welche eine Immunsuppression bedingt"
},
{
"language" : "fr-CH",
"value" : "Maladie rhumatismale ou auto-immune allant nécessiter une immunosuppression"
},
{
"language" : "it-CH",
"value" : "Malattia reumatica o autoimmune che presto richiederà l'immunosoppressione"
},
{
"language" : "rm-CH",
"value" : "RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT"
},
{
"language" : "en-US",
"value" : "RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT"
}
]
},
{
"code" : "114032",
"display" : "SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL",
"designation" : [
{
"language" : "de-CH",
"value" : "Schädelbasisfraktur /-Missbildung, zerebrospinale Liquorfistel"
},
{
"language" : "fr-CH",
"value" : "Fracture ou malformation de la base du crâne, fistule de liquide céphalo-rachidien"
},
{
"language" : "it-CH",
"value" : "Frattura o malformazione della base del cranio, fistola di liquido cerebrospinale"
},
{
"language" : "rm-CH",
"value" : "SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL"
},
{
"language" : "en-US",
"value" : "SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL"
}
]
},
{
"code" : "114028",
"display" : "SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE",
"designation" : [
{
"language" : "de-CH",
"value" : "Schwangerschaft und post-partum Periode"
},
{
"language" : "fr-CH",
"value" : "Grossesse et post-partum"
},
{
"language" : "it-CH",
"value" : "Gravidanza e post-parto"
},
{
"language" : "rm-CH",
"value" : "SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE"
},
{
"language" : "en-US",
"value" : "SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE"
}
]
},
{
"code" : "113021",
"display" : "SCHWERE_NEURODERMITIS_BEIM_KIND",
"designation" : [
{
"language" : "de-CH",
"value" : "Schwere Neurodermitis beim Kind"
},
{
"language" : "fr-CH",
"value" : "Eczema sévère chez l’enfant"
},
{
"language" : "it-CH",
"value" : "Eczema severo nel bambino"
},
{
"language" : "rm-CH",
"value" : "SCHWERE_NEURODERMITIS_BEIM_KIND"
},
{
"language" : "en-US",
"value" : "SCHWERE_NEURODERMITIS_BEIM_KIND"
}
]
},
{
"code" : "114004",
"display" : "SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN",
"designation" : [
{
"language" : "de-CH",
"value" : "Schweres Asthma: bei verlängerter oder häufiger Behandlung mit oralen Steroiden"
},
{
"language" : "fr-CH",
"value" : "Asthme sévère : si traitement prolongé ou fréquent par des corticoïdes oraux"
},
{
"language" : "it-CH",
"value" : "Asma severa : se trattamento prolungato o frequente con corticoidi orali"
},
{
"language" : "rm-CH",
"value" : "SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN"
},
{
"language" : "en-US",
"value" : "SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN"
}
]
},
{
"code" : "114014",
"display" : "SICHELZELLANAEMIE",
"designation" : [
{
"language" : "de-CH",
"value" : "Sichelzellanämie"
},
{
"language" : "fr-CH",
"value" : "Anémie falciforme"
},
{
"language" : "it-CH",
"value" : "Anemia falciforme"
},
{
"language" : "rm-CH",
"value" : "SICHELZELLANAEMIE"
},
{
"language" : "en-US",
"value" : "SICHELZELLANAEMIE"
}
]
},
{
"code" : "113036",
"display" : "ZOELIAKIE",
"designation" : [
{
"language" : "de-CH",
"value" : "Zöliakie"
},
{
"language" : "fr-CH",
"value" : "Coeliaquie"
},
{
"language" : "it-CH",
"value" : "Celiachia"
},
{
"language" : "rm-CH",
"value" : "ZOELIAKIE"
},
{
"language" : "en-US",
"value" : "ZOELIAKIE"
}
]
}
]
}
IG © 2021+ HL7 Switzerland. Package ch.fhir.ig.ch-vacd#3.0.0 based on FHIR 4.0.1. Generated 2022-12-21
Links: Table of Contents |
QA Report
| Propose a change